EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism

Geke C Poolen, Rolf T Urbanus, Mark Roest, Geert-Jan Geersing, Bas de Laat, Roger E G Schutgens

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.04.030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Geke C Poolen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Ne…. Hauptthemen laut MEDLINE: Venous Thromboembolism, von Willebrand Factor, Anticoagulants, Blood Coagulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Venous thromboembolism (VTE) can recur shortly after stopping anticoagulation, highlighting the need for reliable biomarkers to identify high-risk patients during treatment. OBJECTIVES: To determine whether platelet and endothelial markers predict VTE recurrence. METHODS: We used data and samples from the randomized controlled VISTA trial (2011-2015), which included patients with unprovoked VTE who were treated with vitamin K antagonists for 6 months. After treatment cessation, patients were followed for 2 years to assess recurrence. This dataset formed the basis for the current prospective analysis, in which plasma levels of von Willebrand factor (VWF), active VWF (aVWF), soluble P-selectin, soluble thrombomodulin, CXCL4, and CXCL7 were measured before and after cessation of anticoagulation. Associations between biomarker levels and recurrence were analyzed using Cox regression. RESULTS: Plasma samples from 629 patients with a first unprovoked VTE who discontinued vitamin K antagonists were analyzed. Recurrence occurred in 75 patients (12%); 11 (15%) within 1 month, 29 (39%) within 3 months, and 46 (61%) after 3 months. Elevated levels of VWF and aVWF were associated with an increased risk of recurrence per 10-unit increase (VWF: hazard ratio, 1.03; 95% CI, 1.01-1.06; aVWF: hazard ratio, 1.02; 95% CI, 1.00-1.05). Associations were stronger for early recurrence ( 3 months). Stratification showed that VWF and aVWF were associated with increased recurrence risk in men, but not in women. CONCLUSION: Elevated levels of VWF and aVWF during anticoagulation were associated with early recurrence in men and might serve as biomarkers for predicting VTE recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous Thromboembolismvon Willebrand FactorAnticoagulantsBlood CoagulationHumansFemaleRecurrenceMaleBiomarkersMiddle AgedAgedProspective StudiesVitamin KRisk FactorsTime FactorsTreatment OutcomeUp-RegulationAdult

Stichwörter der Autor:innen

anticoagulantsbiomarkersrecurrencevenous thromboembolismvon Willebrand factor

Substanzen

von Willebrand FactorAnticoagulantsBiomarkersVitamin K

Autor:innen und Institutionen

  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Functional Coagulation, Synapse Research Institute, Maastricht, the Netherlands.
  • Department General Practice & Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: R.T.Urbanus@umcutrecht.nl.

Förderung

  • ZonMw

Zitieren

APA

Poolen, G. C., Urbanus, R. T., Roest, M., Geersing, G. J., de Laat, B., & Schutgens, R. E. G. (2025). Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.04.030

Vancouver

Poolen GC, Urbanus RT, Roest M, Geersing GJ, de Laat B, Schutgens REG. Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.04.030

BibTeX
@article{Poolen2025,
  author = {Poolen, Geke C and Urbanus, Rolf T and Roest, Mark and Geersing, Geert-Jan and de Laat, Bas and Schutgens, Roger E G},
  title = {Elevated levels of (active) von Willebrand factor during anticoagulation are associated with early recurrence of venous thromboembolism},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.04.030}
}
Kostenlos starten →